BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21325100)

  • 21. [The intracarotid amobarbital test. Neuroradiologic and neuropsychologic aspects].
    Kurthen M; Solymosi L; Linke D
    Radiologe; 1993 Apr; 33(4):204-12. PubMed ID: 8506409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance.
    Fujii M; Miyachi S; Matsubara N; Kinkori T; Takebayashi S; Izumi T; Ohshima T; Tsurumi A; Hososhima O; Wakabayashi T; Yoshida J
    World Neurosurg; 2011; 75(3-4):503-8. PubMed ID: 21600504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient shivering during Wada test provides insight into human thermoregulation.
    Shah AK; Atkinson MD; Gupta P; Zak I; Watson CE; Rothermel R; Asano E; Fuerst D
    Epilepsia; 2010 May; 51(5):745-51. PubMed ID: 19919666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracarotid propofol testing: a comparative study with amobarbital.
    Mikati MA; Naasan G; Tarabay H; El Yamen S; Baydoun A; Comair YG
    Epilepsy Behav; 2009 Mar; 14(3):503-7. PubMed ID: 19162226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intracarotid etomidate Wada test: a 54-patient series.
    Passarelli V; Pinto LF; Jorge CL; Puglia P; Adda CC; Wen HT; Castro LH
    Epilepsy Behav; 2014 Oct; 39():73-7. PubMed ID: 25216069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Presurgical neuropsychological assessment in epilepsy: the Wada test].
    Andelman F; Neufeld M; Reider-Groswasser I; Kremer U; Segev Y; Fried I
    Harefuah; 2000 Mar; 138(6):440-4, 519. PubMed ID: 10883155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propofol as a substitute for amobarbital in Wada testing.
    Chiu AH; Bynevelt M; Lawn N; Lee G; Singh TP
    J Clin Neurosci; 2015 Nov; 22(11):1830-2. PubMed ID: 26188665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is the current role of a Wada test in the pre-surgical work-up of pharmacologically intractable epilepsy in adults?].
    Valton L; Mascott CR
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S164-9. PubMed ID: 15331962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications during the Wada test.
    Loddenkemper T; Morris HH; Möddel G
    Epilepsy Behav; 2008 Oct; 13(3):551-3. PubMed ID: 18590981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracarotid amobarbital procedure. The Wada test.
    Trenerry MR; Loring DW
    Neuroimaging Clin N Am; 1995 Nov; 5(4):721-8. PubMed ID: 8564293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does lateralized hemispheric control of cardiovascular activity exist? A Wada test study].
    Reuter BM; Kurthen M; Linke DB
    Z Exp Angew Psychol; 1993; 40(2):267-78. PubMed ID: 8372483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wada testing in pediatric patients by use of propofol anesthesia.
    Masters LT; Perrine K; Devinsky O; Nelson PK
    AJNR Am J Neuroradiol; 2000 Aug; 21(7):1302-5. PubMed ID: 10954283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on determination of language dominance in screening for epilepsy surgery: the Wada test and newer noninvasive alternatives.
    Abou-Khalil B
    Epilepsia; 2007 Mar; 48(3):442-55. PubMed ID: 17319925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intracarotid amobarbital or Wada test: unilateral or bilateral?
    Uijl SG; Leijten FS; Arends JB; Parra J; van Huffelen AC; van Rijen PC; Moons KG
    Acta Neurol Scand; 2009 Mar; 119(3):199-206. PubMed ID: 18684215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FMRI reveals functional cortex in a case of inconclusive Wada testing.
    Lanzenberger R; Wiest G; Geissler A; Barth M; Ringl H; Wöber C; Gartus A; Baumgartner C; Beisteiner R
    Clin Neurol Neurosurg; 2005 Feb; 107(2):147-51. PubMed ID: 15708233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tolerability and adverse effects of propofol in the Wada test].
    Castro-Macías JI; Pérez-Reyes SP; García-Cazarez R; Pérez-Careta MC; Díaz-Campos MO; Salazar-Hörner DL; Preciado-Gutiérrez OU; Ruíz-Velázquez F
    Rev Neurol; 2021 Mar; 72(5):151-156. PubMed ID: 33616197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory performance during the intracarotid amobarbital procedure and neuropsychological assessment in medial temporal lobe epilepsy: the limits of material specificity.
    Vingerhoets G; Miatton M; Vonck K; Seurinck R; Boon P
    Epilepsy Behav; 2006 Mar; 8(2):422-8. PubMed ID: 16412696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of adverse effects in intracarotid propofol injection for Wada test.
    Mikuni N; Takayama M; Satow T; Yamada S; Hayashi N; Nishida N; Taki J; Enatsu R; Ikeda A; Miyamoto S; Hashimoto N
    Neurology; 2005 Dec; 65(11):1813-6. PubMed ID: 16148262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous methylprednisolone reduces the risk of propofol-induced adverse effects during Wada testing.
    Mikuni N; Yokoyama Y; Matsumoto A; Kikuchi T; Yamada S; Hashimoto N; Miyamoto S
    Neurol Med Chir (Tokyo); 2010; 50(8):622-6. PubMed ID: 20805642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has amobarbital expired? Considering the future of the Wada.
    Grote CL; Meador K
    Neurology; 2005 Dec; 65(11):1692-3. PubMed ID: 16344509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.